Intrapartum antibiotics for known maternal Group B streptococcal colonization

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 1, 2013, Pages

  Ohlsson, Arne ^a   Shah, Vibhuti S ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; PENICILLIN DERIVATIVE; PLACEBO; ANTIINFECTIVE AGENT; PENICILLIN G;

ALL CAUSE MORTALITY; ANTIBIOTIC PROPHYLAXIS; BACTERIAL COLONIZATION; BACTERIAL INFECTION; CAUSE OF DEATH; CLINICAL EFFECTIVENESS; COMPARATIVE STUDY; DRUG RESPONSE; EVIDENCE BASED MEDICINE; GROUP B STREPTOCOCCAL INFECTION; HUMAN; INTRAPARTUM CARE; MATERNAL MORBIDITY; META ANALYSIS; NEWBORN; NEWBORN INFECTION; NEWBORN MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; STATISTICAL BIAS; SYSTEMATIC REVIEW; DISEASE TRANSMISSION; FEMALE; HETEROZYGOTE; LABOR; METHODOLOGY; PREGNANCY; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION; VERTICAL TRANSMISSION;

AMPICILLIN; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; CARRIER STATE; FEMALE; HUMANS; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; LABOR, OBSTETRIC; PENICILLIN G; PENICILLINS; PREGNANCY; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE;

MLCS; MLOWN;

EID: 84874814778     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD007467.pub3     Document Type: Review

References (101)

1. Boyer KM, Gadzala CA, Kelly PC, Gotoff SP. Ampicillin prophylaxis of group B streptococcal transmission in high-risk parturient women. Pediatric Research 1982;16:280A.
2. Boyer KM, Gadzala CA, Kelly PD, Gotoff SP. Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. III. Interruption of mother-to-infant transmission. Journal of Infectious Diseases 1983;148:810-6.
3. Boyer KM, Gotoff SP. Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis. New England Journal of Medicine 1986;314:1665-9.
4. Gotoff SP. Chemoprophylaxis of early onset group B streptococcal disease. Pediatric Infectious Disease 1984;3(5):401-3.
5. Edwards R, Clark P, Duff P. Intrapartum antibiotic prophylaxis with either penicillin or ampicillin may increase the rate of neonatal sepsis caused by ampicillin-resistant Gram-negative bacteria. American Journal of Obstetrics and Gynecology 2001;185:S190.
6. Edwards RK, Clark P, Sistrom CL, Duff P. Intrapartum antibiotic prophylaxis 1: relative effects of recommended antibiotics on Gram-negative pathogens. Obstetrics & Gynecology 2002;100:534-9.
7. Matorras R, Garcia-Perea A, Omenaca F, Diez-Enciso M, Madero R, Usandizaga JA. Intrapartum chemoprophylaxis of early-onset group B streptococcal disease. European Journal of Obstetrics & Gynecology and Reproductive Biology 1991;40(1):57-62.
8. Mattoras R, Garcia-Perea A, Madero R, Usandizaga JA. Maternal colonization by group B streptococci and puerperal infection; analysis of intrapartum chemoprophylaxis. European Journal of Obstetrics & Gynecology and Reproductive Biology 1990;38(3):203-7.
9. Omenaca Teres F, Matorras R, García Perea A, Elorza MD. Prevention of neonatal group B streptococcal sepsis. Pediatric Infectious Disease Journal 1987;6(9):874.
10. Tuppurainen N, Hallman M. Prevention of neonatal group B streptococcal disease: intrapartum detection and chemoprophylaxis of heavily colonized parturients. Obstetrics & Gynecology 1989;75:583-7.
11. Tuppurainen N, Österlund K, Hallman M. Selective intrapartum penicillin prophylaxis of early onset group B streptococcal disease. Pediatric Research 1986;20(4 Pt 2):403A.
12. Belady P, Graham S, Lesotte D, Merenstein G, Gibbs R. Does the use of ampicillin versus penicillin for the prevention of neonatal group B streptococcal (GBS) infection result in higher rates of colonization with resistant organisms?. Infectious Diseases in Obstetrics and Gynecology 1996;4:54.
13. Davies JK, Barrenachea J, Mackenzie T, Gibbs RS. Maternal infections following intrapartum GBS prophylaxis. Infectious Diseases in Obstetrics and Gynecology 1998;6(2):80.
14. Dykes AK, Christensen KK, Christensen P. Chlorhexidine for prevention of neonatal colonization with group B streptococci. IV. Depressed puerperal carriage following vaginal washing with chlorhexidine during labour. European Journal of Obstetrics & Gynecology and Reproductive Biology 1987;24:293-7.
15. Easmon CSF, Hastings MJG, Deeley J, Bloxham B, Rivers RPA, Marwood R. The effect of intrapartum chemoprophylaxis on the vertical transmission of group B streptococci. British Journal of Obstetrics and Gynaecology 1983;90:633-5.
16. Facchinetti F, Piccinini F, Mordini B. Prophylaxis of group B streptococcus vertical transmission by using vaginal chlorhexidine. American Journal of Obstetrics and Gynecology 1999;180(1 Pt 2):S84.
17. Facchinetti F, Piccinini F, Mordini B, Volpe A. Chlorhexidine vaginal flushings versus systemic ampicillin in the prevention of vertical transmission of neonatal group B streptococcus, at term. Journal of Maternal-Fetal and Neonatal Medicine 2002;11:84-8.
18. Gibbs RS, McNabb F. Randomized clinical trial of intrapartum clindamycin cream for reduction of group B streptococcal maternal and neonatal colonization. Infectious Diseases in Obstetrics and Gynecology 1996;4(1):25-7.
19. Merenstein GB, Todd WA, Brown G, Yost CC, Luzier T. Group B beta-hemolytic streptococcus: randomized controlled treatment study at term. Obstetrics & Gynecology 1980;55(3):315-8.
20. Lim DV, Morales WJ, Walsh AF, Kazaniz D. Reduction of morbidity and mortality rates for neonatal group B streptococcal disease through early diagnosis and chemoprophylaxis. Journal of Clinical Microbiology 1986;23:489-92.
21. Morales WJ, Lim DV, Walsh AF. Prevention of neonatal group B streptococcal sepsis by the use of a rapid screening test and selective intrapartum prophylaxis. American Journal of Obstetrics and Gynecology 1986;155:979-83.
22. Pinette M, Thayer K, Wax J, Blackstone J, Cartin A. Efficacy of intramuscular penicillin in the eradication of group b streptococcal colonization at delivery. American Journal of Obstetrics and Gynecology 2003;189(6 Suppl 1):S96.
23. Pinette MG, Thayer K, Wax JR, Blackstone J, Cartin A. Efficacy of intramuscular penicillin in the eradication of group B streptococcal colonization at delivery. Journal of Maternal-Fetal and Neonatal Medicine 2005;17(5):333-5.
24. Sáez-Llorens X, Ah-Chu MS, Castaňo E, Cortés L, Torres A, Suárez, Bissot A, et al.Intrapartum prophylaxis with ceftriaxone decreases rates of bacterial colonization and early-onset infection in newborns. Clinical Infectious Diseases 1995;21(4):876-80.
25. American Academy of Pediatrics, Committee on Infectious Diseases and Committee on Fetus and Newborn. Guidelines for prevention of group B streptococcal infection by chemoprophylaxis. Pediatrics 1992;90:775-8.
26. American Academy of Pediatrics, Committee on Infectious Diseases/Committee on Fetus and Newborn. Revised guidelines for prevention of early-onset group B streptococcal (GBS) disease. Pediatrics 1997;99:489-96.
27. Ablow RC, Driscoll SG, Effman EL, Gross I, Jolles CJ, Uauy R, et al.A comparison of early-onset group B streptococcal neonatal infection and the respiratory distress syndrome of the newborn. New England Journal of Medicine 1976;294:65-70.
28. Committee on Technical Bulletins of the American College of Obstetricians and Gynecologists. Group B streptococcal infections in pregnancy. ACOG Technical Bulletin no. 170. ACOG, July 1992.
29. American College of Obstetricians and Gynecologists, Committee on Obstetric Practice. Prevention of early-onset group B streptococcal disease in newborns [Opinion 173]. Washington DC: American College of Obstetricians and Gynecologists, 1996.
30. Allardice JG, Baskett TF, Seshia MMK, Bowman N, Malazdrewicz R. Perinatal group B streptococcal colonization and infection. American Journal of Obstetrics and Gynecology 1982;142:617-20.
31. Baker CJ, Barrett FF. Transmission of group B streptococci among parturient women and their neonates. Journal of Pediatrics 1973;83:919-25.
32. Barcaite E, Bartusevicius A, Tameliene R, Kliucinskas M, Maleckiene L, Nadisauskiene R. Prevalence of maternal group B streptococcal colonisation in European countries. Acta Obstetricia et Gynecologica Scandinavica 2008;87(3):260-71.
33. Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, et al.Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA 1996;276:637-9.
34. Bergqvist G. Neonatal infections caused by group B streptococci. Scandinavian Journal of Infectious Diseases 1974;6:29-31.
35. Berthier A, Senthiles L, Hamou L, Renoult-Litzler D, Marret S, Marpeau L. Antibiotics at term. Questions about five allergic accidents. Gynécologie, Obstétrique & Fertilité 2007;35:464-72.
36. Boyer KM, Gadzala CA, Kelly PC, Gotoff SP. Ampicillin prophylaxis of group B streptococcal transmission in high-risk parturient women. Pediatric Research 1982;16:280A.
37. Boyer KM, Gadzala CA, Kelly PD, Gotoff SP. Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. III. Interruption of mother-to-infant transmission. Journal of Infectious Diseases 1983;148:810-6.
38. Carbonell-Estrany X, Figueras-Aloy J, Salcedo-Abizanda S, de la Rosa-Fraile M, Castrillo Study Group. Probable early-onset group B streptococcal neonatal sepsis: a serious clinical condition related to intrauterine infection. Archives of Disease in Childhood. Fetal Neonatal Edition 2008;93(2):F85-F89.
39. Cayeux P. Neonatal infections with B group streptococci. Etiological verification. Apropos of 77 cases [Infections néonatales à streptocoques du groupe B. Constatations etiologiques. A propos de 77 observations]. Archives Françaises de Pédiatrie 1972;29(4):391-6.
40. Centers for Disease Control and Prevention (CDC). Prevention of perinatal group B streptococcal disease: a public health perspective. Morbidity and Mortality Weekly Report 1996;45 (RR-7):1-24.
41. Centers for Disease Control and Prevention (CDC). Prevention of perinatal group B streptococcal disease. Morbidity and Mortality Weekly Reports 2002;51 (RR11):1-22.
42. Centers for Disease Control and Prevention (CDC). Early-onset and late-onset neonatal group B streptococcal disease--United States, 1996-2004. Morbidity and Mortality Weekly Report 2005;54(47):1205-8.
43. Centers for Disease Control and Prevention (CDC). Perinatal group B streptococcal disease after universal screening recommendations--United States, 2003-2005. Morbidity and Mortality Weekly Report 2007;56:701-5.
44. Christensen KK, Christensen P, Dahlander K, Linden V, Lindroth M, Svenningsen N. The significance of group B streptococci in neonatal pneumonia. European Journal of Pediatrics 1983;140:118-22.
45. Davies JK, Barrenachea J, Mackenzie T, Gibbs RS. Maternal infections following intrapartum GBS prophylaxis. Infectious Diseases in Obstetrics and Gynecology 1998;6(2):80.
46. Dillon HC, Khare S, Gray BM. Group B streptococcal carriage and disease: a 6-year prospective study. Journal of Pediatrics 1987;110:31-6.
47. Dinsmoor MJ, Viloria R, Leif L, Elder S. Use of intrapartum antibiotics and the incidence of postnatal maternal and neonatal yeast infections. Obstetetrics & Gynecology 2005;106:19-22.
48. Edwards RK, Clark P, Sistrom CL, Duff P. Intrapartum antibiotic prophylaxis 1: Relative effects of recommended antibiotics on gram-negative pathogens. Obstetrics & Gynecology 2002;100:534-9.
49. Eickhoff TC, Klein JO, Daly AK, Ingall D, Finland M. Neonatal sepsis and other infections due to group B beta-hemolytic streptococci. New England Journal of Medicine 1964;271:1221-8.
50. Fliegner JR, Garland SM. Perinatal mortality in Victoria, Australia; role of group B streptococcus. American Journal of Obstetrics and Gynecology 1990;163:1609-11.
51. Garland SM. Early onset neonatal group B streptococcus (GBS) infection: associated obstetric risk factors. Australian and New Zealand Journal of Obstetrics and Gynaecology 1991;10:801-8.
52. Gavino M, Wang E. A comparison of a new rapid real-time polymerase chain reaction system to traditional culture in determining group B streptococcus colonization. American Journal of Obstetrics and Gynecology 2007;197(4):388.e1-388.e4.
53. Goldenberg RL, McClure EM, Saleem S, Rouse D, Vermund S. Use of vaginally administered chlorhexidine during labor to improve pregnancy outcomes. Obstetetrics & Gynecology 2006;107:1139-46.
54. Gotoff SP. Chemoprophylaxis of early onset group B streptococcal disease. Pediatric Infectious Disease 1984;3(5):401-3.
55. Group B Strep Association. Historical background. http://www.groupbstrep.org (accessed 2008).
56. Hamada S, Vearncombe M, McGeer A, Shah PS. Neonatal group B streptococcal disease: incidence, presentation, and mortality. Journal of Maternal-Fetal and Neonatal Medicine 2008;21:53-7.
57. Hannah ME, Ohlsson A, Wang EEL, Matlow A, Foster GA, Willan AR, et al.Maternal colonization with group B streptococcus and prelabor rupture of the membranes at term: the role of induction of labor. American Journal of Obstetrics and Gynecology 1997;177:780-5.
58. Hastings MJG, Easmon CSF, Neill J, Bloxham B, Rivers RPA. Group B streptococcal colonisation and the outcome of pregnancy. Journal of Infection 1986;12:23-9.
59. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60.
60. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2008]. The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org.
61. Ho CM, Chi CY, Ho MW, Chen CM, Liao WC, Liu YM, et al.Clinical characteristics of group B streptococcus bacteremia in non-pregnant adults. Journal of Microbiology, Immunology and Infection 2006;39:396-401.
62. Honest H, Sharma S, Khan KS. Rapid tests for group B streptococcus colonization in laboring women: a systematic review. Pediatrics 2006;117:1055-66.
63. Håkansson S, Källén K. Impact and risk factors for early-onset group B streptococcal morbidity: analysis of a national, population-based cohort in Sweden 1997-2001. BJOG: an international journal of obstetrics and gynaecology 2006;113:1452-8.
64. Institute of Medicine. Prospects for immunizing against Streptococcus Group B. New vaccine development. Establishing priorities. Diseases of importance in the United States. Vol. 1, Washington, DC: National Academy Press, 1985.
65. Jao MS, Cheng PJ, Shaw SW, Soong YK. Anaphylaxis to cefazolin during labor secondary to prophylaxis for group B Streptococcus: a case report. Journal of Reproductive Medicine 2006;51(8):655-8.
66. Johri AK, Paoletti LC, Glaser P, Dua M, Sharma PK, Grandi G, et al.Group B Streptococcus: global incidence and vaccine development. Nature Reviews. Microbiology 2006;4:932-42.
67. Lancefield R. A serological differentiation of human and other groups of haemolytic streptococci. Journal of Experimental Medicine 1933;57:571-95.
68. Lancefield R, Hare R. The serological differentiation of pathogenic and non-pathogenic strains of haemolytic streptococci from parturient women. Journal of Experimental Medicine 1935;61:335-49.
69. Lloyd DJ, Reid TM. Group B streptococcal infection in the newborn. Criteria for early detection and treatment. Acta Paediatrica Scandinavica 1976;65(5):585-91.
70. Matorras R, Garcia-Perea A, Omenaca F, Diez-Enciso M, Madero R, Usandizaga JA. Intrapartum chemoprophylaxis of early-onset group B streptococcal disease. European Journal of Obstetrics & Gynecology and Reproductive Biology 1991;40(1):57-62.
71. McCracken GH. Group B streptococci: the new challenge in neonatal infections. Journal of Pediatrics 1973;82:703-6.
72. McNanley AR, Glantz C, Hardy DJ, Vicino D. The effect of intrapartum penicillin on vaginal group B streptococcus colony counts. American Journal of Obstetrics and Gynecology 2007;197(6):583.e1-583.e4.
73. Mereghetti L, Lanotte P, Rochoux A, Sauget AS, Chevillot M, Perrotin F, et al.Application of the French guidelines for preventing neonatal group B streptococcal disease in a university hospital. Clinical Microbiology and Infection 2007;13:322-4.
74. Nyhan WL, Fousek MD. Septicemia of the newborn. Pediatrics 1958;22:268-78.
75. Ohlsson A, Bailey T, Takieddine F. Changing etiology and outcome of neonatal septicemia in Riyadh, Saudi Arabia. Acta Paediatrica Scandinavica 1986;75:540-44.
76. Ohlsson A. Perinatal group B streptococcal infections. Canadian Journal of Obstetrics/Gynaecology & Women's Health Care 1992;4:355-63.
77. Ohlsson A, Myhr TL. Intrapartum chemoprophylaxis of perinatal group B streptococcal infections: a critical review of randomized controlled trials. American Journal of Obstetrics and Gynecology 1994;170:910-7.
78. Ohlsson A, Walia R. Differences between information provided in abstracts of randomized controlled trials in neonates submitted to the Annual Meeting of the American Pediatric Society and the Society for Pediatric Research (APS/SPR) and final publications? Implications for meta-analyses. VII Cochrane Colloquium. The best evidence for health care: the role of the Cochrane Collaboration; 1999 October 6-9; Rome, Italy. 1999.
79. Omenaca Teres F, Matorras R, García Perea A, Elorza MD. Prevention of neonatal group B streptococcal sepsis. Pediatric Infectious Disease Journal 1987;6(9):874.
80. Osrin D, Vergnano S, Costello A. Serious bacterial infections in newborn infants in developing countries. Currrent Opinion in Infectious Diseases 2004;17:217-24.
81. Royal College of Obstetricians and Gynaecologists. Prevention of early onset neonatal group B streptococcal disease. http://www.rcog.org.uk/resources/Public/pdf/GroupB_strep_no36.pdf (accessed 2008) 2003.
82. The Cochrane Collaboration. Review Manager (RevMan). 5.0. Copenhagen, The Nordic Cochrane Centre: The Cochrane Collaboration, 2008.
83. Schrag SJ, Zell ER, Lynfield R, Roome A, Arnold K, Craig AS, et al.A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. New England Journal of Medicine 2002;347:233-9.
84. Schröder H, Paust H. Group B streptococci: the most common cause of neonatal septicemia [B-Streptokokken als haufigste Erreger der Neugeborenensepsis. Einleitung, Haufigkeit, Klinik, Therapie]. Monatsschrift für Kinderheilkunde 1979;127:720-3.
85. Schuchat A, Oxtoby M, Cochi S, Sikes RK, Hightower A, Plikaytis B, et al.Population-based risk factors for neonatal Group B streptococcal disease: results of a cohort study in metropolitan Atlanta. Journal of Infectious Diseases 1990;162:672-7.
86. Shah V, Ohlsson A, The Canadian Task Force on Preventive Health Care. Prevention of early-onset Group B Streptococcal (GBS) infection in the newborn: systematic review and recommendations. Technical report. The CanadianTask Force on Preventive Health Care (www.ctfphc.org) (accessed 2008) 2001.
87. Sinah A, Lieu TA, Paoletti LC, Weinstein MC, Platt R. The projected health benefits of maternal group B streptococcal vaccination in the era of chemoprophylaxis. Vaccine 2005;23:3187-95.
88. Slotved H-C, Kong F, Lambertsen L, Sauer S, Gilbert GL. Serotype IX, a proposed new Streptococcus agalactiae serotype. Journal of Clinical Microbiology 2007;45:2929-36.
89. Society of Obstetricians and Gynaecologists of Canada, Canadian Paediatric Society. National consensus statement on the prevention of early onset group B streptococcal infections in the newborn. Journal of the Society of Obstetricians and Gynaecologists of Canada 1994;16:2271-8.
90. Society of Obstetricians and Gynaecologists. Statement on the prevention of early-onset group B streptococcal infections in the newborn. Journal of the Society of Obstetricians and Gynaecologists of Canada 1997;19:751-8.
91. Society of Obstetricians and Gynaecologist of Canada. The prevention of early-onset group B streptococcal infections in newborns. Journal of Obstetrics and Gynaecology of Canada 2004;26:826-32.
92. Stade B, Shah V, Ohlsson A. Vaginal chlorhexidine during labour to prevent early-onset neonatal group B streptococcal infection. Cochrane Database of Systematic Reviews 2004, Issue 3. [DOI: 10.1002/14651858.CD003520.pub2]
93. Stoll BJ, Schuchat A. Maternal carriage of group B streptococci in developing countries. Pediatric Infectious Disease Journal 1998;17(6):499-503.
94. Van den Akker van Marle ME, Rijnders MEB, van Dommelen P, Fekkes M, van Wouwe JP, Amelink-Verburg MP, et al.Cost-effectiveness of different treatment strategies with intrapartum antibiotic prophylaxis to prevent early-onset group B streptococcal disease. BJOG: an international journal of obstetrics and gynaecology 2005;112:820-6.
95. Vesikari T, Isolauri E, Tuppurainen N, Janas M, Koivisto M, Kero P, et al.Neonatal septicaemia in Finland 1981-85. Predominance of group B streptococcal infections with very early onset. Acta Paediatrica Scandinavica 1989;78:44-50.
96. Wood EG, Dillon HC. A prospective study of group B streptococcal bacteriuria in pregnancy. American Journal of Obstetrics and Gynecology 1991;140:515-20.
97. Yagupsky P, Menegus MA, Powell KR. The changing spectrum of group B streptococcal disease in infants: an eleven-year experience in a tertiary care hospital. Pediatric Infectious Disease Journal 1991;10:801-8.
98. Yudin MH, Shah V, Ohlsson A, Farine D. Are we using the optimal strategy for GBS management in pregnancy?. Journal of Obstetrics and Gynaecology Canada 2006;28:499-500.
99. Yow MD, Mason EO, Leeds LJ, Thompson PK, Clark DJ, Gardener SE. Ampicillin prevents intrapartum transmission of group B streptococcus. JAMA 1979;241:1245-7.
100. Smaill F. Intrapartum antibiotics for Group B streptococcal colonisation. Oxford database of perinatal trials 1992; Vol. Version 1.3, Disk Issue 7:Record 3006.
101. Smaill FM. Intrapartum antibiotics for Group B streptococcal colonisation. Cochrane Database of Systematic Reviews 1996, Issue 1. [DOI: 10.1002/14651858.CD000115]